» Articles » PMID: 31191641

Microbial Profiles and Risk Factors of Preexisting Biliary Infection in Patients with Therapeutic Endoscopy

Overview
Publisher Wiley
Specialty Gastroenterology
Date 2019 Jun 14
PMID 31191641
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The bile infection may already exist before the administration of an interventional procedure, despite no clinical manifestations of cholangitis detected. Blood cultures remained negative even in more than half of the febrile cases with cholangitis. Risk factors associated with bacterial growth in bile before the intervention are not well defined. To establish the bacterial profiles isolated from the bile samples and to identify risk factors for bacterial colonization in the bile system.

Methods: Individuals who underwent endoscopic retrograde cholangiopancreatography (ERCP) interventions were enrolled. Bile samples were aspirated and were immediately transferred into a sterile tube for storage.

Results: Positive bile cultures were detected in 363 (38.0%) of 956 patients, including 322 benign diseases and 41 malignances. Of 363 positive cases, 351 (96.7%) were monoinfection and 12 (3.3%) multi-infection. were the most common Gram-negative bacteria (210, 56.0%), followed by (45, 12.0%). represented the most common Gram-positive microorganism (19, 5.07%), while (11, 2.93%) were the dominant fungi. were more frequently detected in malignant diseases ( = 0.046). Age, previous ERCP history or OLT history, and CBD diameter were independent risk factors for positive cultures ( < 0.05) while preoperative jaundice drug therapy was the protective factor for bile infection ( < 0.05).

Conclusion: Monomicrobial infection was dominant among all infections, and strains were more frequently isolated from patients with malignant diseases. To effectively manage patients who are at a high risk for bile infection, a detailed diagnosis and treatment plan for each case should be prepared.

Citing Articles

Microbial profile of biliary tract infection in patients undergoing therapeutic endoscopic retrograde cholangiopancreatography (ERCP), and baseline risk factors predicting microbial growth and post-ERCP cholangitis.

Ismail H, Yaseen Khan R, Laeeq S, Majid Z, Tasneem A, Hanif F Prz Gastroenterol. 2025; 19(3):296-302.

PMID: 39802970 PMC: 11718497. DOI: 10.5114/pg.2024.136226.


Preventive Antibiotic Use and Complications After Endoscopic Retrograde Cholangiopancreatography in Patients Hospitalized for Primary Sclerosing Cholangitis.

Uwumiro F, Anighoro S, Bojerenu M, Akpabio N, Asogwa S, Okpujie V Cureus. 2024; 16(7):e64429.

PMID: 39131042 PMC: 11317107. DOI: 10.7759/cureus.64429.


The distribution and antibiotic-resistant characteristics and risk factors of pathogens associated with clinical biliary tract infection in humans.

Chen S, Lai W, Song X, Lu J, Liang J, Ouyang H Front Microbiol. 2024; 15:1404366.

PMID: 38784792 PMC: 11112516. DOI: 10.3389/fmicb.2024.1404366.


Incidence of bactibilia and related factors in patients who undergo cholecystectomy.

Moon D, Kang J, Byun Y, Choi Y, Lee H, Jang J Ann Surg Treat Res. 2023; 104(1):10-17.

PMID: 36685772 PMC: 9830044. DOI: 10.4174/astr.2023.104.1.10.


Biliary infection; distribution of species and antibiogram study.

Shafagh S, Rohani S, Hajian A Ann Med Surg (Lond). 2021; 70:102822.

PMID: 34540214 PMC: 8435813. DOI: 10.1016/j.amsu.2021.102822.


References
1.
Masci E, Toti G, Mariani A, Curioni S, Lomazzi A, Dinelli M . Complications of diagnostic and therapeutic ERCP: a prospective multicenter study. Am J Gastroenterol. 2001; 96(2):417-23. DOI: 10.1111/j.1572-0241.2001.03594.x. View

2.
Kiesslich R, Holfelder M, Will D, Hahn M, Nafe B, Genitsariotis R . [Interventional ERCP in patients with cholestasis. Degree of biliary bacterial colonization and antibiotic resistance]. Z Gastroenterol. 2001; 39(12):985-92. DOI: 10.1055/s-2001-19026. View

3.
Rerknimitr R, Fogel E, Kalayci C, Esber E, Lehman G, Sherman S . Microbiology of bile in patients with cholangitis or cholestasis with and without plastic biliary endoprosthesis. Gastrointest Endosc. 2002; 56(6):885-9. DOI: 10.1067/mge.2002.129604. View

4.
Sung J, Costerton J, Shaffer E . Defense system in the biliary tract against bacterial infection. Dig Dis Sci. 1992; 37(5):689-96. DOI: 10.1007/BF01296423. View

5.
Pohl J, Ring A, Stremmel W, Stiehl A . The role of dominant stenoses in bacterial infections of bile ducts in primary sclerosing cholangitis. Eur J Gastroenterol Hepatol. 2005; 18(1):69-74. DOI: 10.1097/00042737-200601000-00012. View